Clinical trial
Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study
NCT01458938 is registered in ClinicalTrials.gov with Carolina Neurosurgery & Spine Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study
- Lead sponsor
- Carolina Neurosurgery & Spine Associates
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 31, 2009
- Completion date
- April 30, 2014
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myelopathy, neurogenic claudication, spinal disease, spinal radiculopathy